CLSI Launches Innovation Series with Reimbursement Panel at Verily
October 24, 2017
The California Life Sciences Institute has launched a new Innovation Series that will focus on issues most pressing for life science startups from the very early to more advanced stage of development. The inaugural session – Reimbursement 101 – took place on October 24 at Verily in South San Francisco and was sponsored by Verify and Hogan Lovells.
Moderated by Jessica Holmes, Executive Director of Reimbursement at Argenta Advisors, the panel explored how provider groups and payers use value in their analysis of what technologies to adopt. For entrepreneurs to succeed in making a difference in human health, they need to design a path forward that will lead to adoption of their technology, with pragmatic considerations at every step. Panelists included John Hernandez, Head of Health Economics and Outcomes Research at Verily Life Sciences, Jennifer Kurkjian, VP of Managed Care and Dignity Health, and Kelvin Lam, MD, Chief Medical Officer at Sutter Health Bay Area.
CLSI is planning additional panels in the Innovation Series for 2018, including a Reimbursement 201 panel. Please contact Lori Lindburg for additional information and sponsorship opportunities.